Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Lancet Regional Health. Europe|December 16, 2024
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trialAntje Schuster, Davide Caimmi, Hendrik Nolte, et al.Expert Review of Respiratory Medicine|June 14, 2023
Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association surveyAngelica Tiotiu, Andras Bikov, Francisco-Javier Gonzalez-Barcala, et al.Allergy|August 23, 2024
Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force reportJulijana Asllani, Dimitrios Mitsias, George Konstantinou, et al.Clinical Reviews in Allergy & Immunology|April 30, 2025
Questionnaire for Clinical Diagnosis of House Dust Mite's Allergy Approved by Delphi ConsensusAngelica Tiotiu, Fulvio Braido, Krysztof Kowal, et al.The World Allergy Organization Journal|August 11, 2020
Beliefs and preferences regarding biological treatments for severe asthmaAndras Bikov, Ipek Kivilcim Oğuzülgen, Ilaria Baiardini, et al.Pageof 2